Licio Collavin

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Topics

Squamous Cell Carcinoma

Endoplasmic Reticulum

Top Venues

Cell death and differentiation

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Elzbieta Panczyszyn, Valentina Saverio, Romina Monzani, Mara Gagliardi, Jelena Petrovic, Jasmina Stojkovska, Licio Collavin, Marco Corazzari
FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target. Cell death discovery 10 (1) (2024)
Rossella De Florian Fania, Arianna Bellazzo, Licio Collavin
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications. Cell death and differentiation 31 (7) (2024)
Rossella De Florian Fania, Arianna Bellazzo, Licio Collavin
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications. Cell death and differentiation 31 (7) (2024)
Elzbieta Panczyszyn, Valentina Saverio, Romina Monzani, Mara Gagliardi, Jelena Petrovic, Jasmina Stojkovska, Licio Collavin, Marco Corazzari
FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target. Cell death discovery 10 (1) (2024)
Rossella De Florian Fania, Arianna Bellazzo, Licio Collavin
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications. Cell death and differentiation (2024)
Rossella De Florian Fania, Arianna Bellazzo, Licio Collavin
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications. Cell death and differentiation 31 (7) (2024)
Elzbieta Panczyszyn, Valentina Saverio, Romina Monzani, Mara Gagliardi, Jelena Petrovic, Jasmina Stojkovska, Licio Collavin, Marco Corazzari
FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target. Cell death discovery 10 (1) (2024)
Mattia Apollonio, Arianna Bellazzo, Nicoletta Franco, Silvia Lombardi, Beatrice Senigagliesi, Loredana Casalis, Pietro Parisse, Agnes Thalhammer, Gabriele Baj, Rossella De Florian Fania, Giannino Del Sal, Licio Collavin
The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells. Cancers 15 (13) (2023)
Arianna Bellazzo, Licio Collavin
Cutting the Brakes on Ras-Cytoplasmic GAPs as Targets of Inactivation in Cancer. Cancers 12 (10) (2020)
Valeria Capaci, Lorenzo Bascetta, Marco Fantuz, Galina V Beznoussenko, Roberta Sommaggio, Valeria Cancila, Andrea Bisso, Elena Campaner, Alexander A Mironov, Jacek R Wiśniewski, Luisa Ulloa Severino, Denis Scaini, Fleur Bossi, Jodi Lees, Noa Alon, Ledia Brunga, David Malkin, Silvano Piazza, Licio Collavin, Antonio Rosato, Silvio Bicciato, Claudio Tripodo, Fiamma Mantovani, Giannino Del Sal
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome. Nature communications 11 (1) (2020)
Daria Sicari, Marco Fantuz, Arianna Bellazzo, Elena Valentino, Mattia Apollonio, Ilaria Pontisso, Francesca Di Cristino, Marco Dal Ferro, Silvio Bicciato, Giannino Del Sal, Licio Collavin
Mutant p53 improves cancer cells' resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6. Oncogene 38 (34) (2019)
Fiamma Mantovani, Licio Collavin, Giannino Del Sal
Mutant p53 as a guardian of the cancer cell. Cell death and differentiation 26 (2) (2018)
Arianna Bellazzo, Giulio Di Minin, Elena Valentino, Daria Sicari, Denis Torre, Luigi Marchionni, Federica Serpi, Michael B Stadler, Daniela Taverna, Gaia Zuccolotto, Isabella Monia Montagner, Antonio Rosato, Federica Tonon, Cristina Zennaro, Chiara Agostinis, Roberta Bulla, Miguel Mano, Giannino Del Sal, Licio Collavin
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells. Cell death and differentiation 25 (7) (2018)
Elena Valentino, Arianna Bellazzo, Giulio Di Minin, Daria Sicari, Mattia Apollonio, Giosuè Scognamiglio, Maurizio Di Bonito, Gerardo Botti, Giannino Del Sal, Licio Collavin
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP. Proceedings of the National Academy of Sciences of the United States of America 114 (29) (2017)
Arianna Bellazzo, Giulio Di Minin, Licio Collavin
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer. Cell death and differentiation 24 (1) (2016)